Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity D Havrylyuk, B Zimenkovsky, O Vasylenko, L Zaprutko, A Gzella, R Lesyk European journal of medicinal chemistry 44 (4), 1396-1404, 2009 | 400 | 2009 |
Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety D Havrylyuk, L Mosula, B Zimenkovsky, O Vasylenko, A Gzella, R Lesyk European Journal of Medicinal Chemistry 45 (11), 5012-5021, 2010 | 357 | 2010 |
Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity D Havrylyuk, B Zimenkovsky, O Vasylenko, A Gzella, R Lesyk Journal of Medicinal Chemistry 55 (20), 8630-8641, 2012 | 291 | 2012 |
Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline–thiazolidine-based hybrids D Havrylyuk, O Roman, R Lesyk European journal of medicinal chemistry 113, 145-166, 2016 | 171 | 2016 |
3D-MoRSE descriptors explained O Devinyak, D Havrylyuk, R Lesyk Journal of Molecular Graphics and Modelling 54, 194-203, 2014 | 160 | 2014 |
Synthesis and anticancer activity of isatin‐based pyrazolines and thiazolidines conjugates D Havrylyuk, N Kovach, B Zimenkovsky, O Vasylenko, R Lesyk Archiv der Pharmazie 344 (8), 514-522, 2011 | 145 | 2011 |
Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones D Havrylyuk, B Zimenkovsky, O Vasylenko, CW Day, DF Smee, P Grellier, ... European journal of medicinal chemistry 66, 228-237, 2013 | 134 | 2013 |
Thiazolidinone motif in anticancer drug discovery. Experience of DH LNMU medicinal chemistry scientific group RB Lesyk, BS Zimenkovsky, DV Kaminskyy, AP Kryshchyshyn, ... Biopolymers and Cell 27 (2), 107-117, 2011 | 132 | 2011 |
5-Ene-4-thiazolidinones induce apoptosis in mammalian leukemia cells J Senkiv, N Finiuk, D Kaminskyy, D Havrylyuk, M Wojtyra, I Kril, A Gzella, ... European Journal of Medicinal Chemistry 117, 33-46, 2016 | 83 | 2016 |
Synthesis of pyrazoline–thiazolidinone hybrids with trypanocidal activity D Havrylyuk, B Zimenkovsky, O Karpenko, P Grellier, R Lesyk European Journal of Medicinal Chemistry 85, 245-254, 2014 | 78 | 2014 |
Synthesis and anticancer activity of novel nonfused bicyclic thiazolidinone derivatives D Havrylyuk, B Zimenkovsky, R Lesyk Phosphorus, Sulfur, and Silicon 184 (3), 638-650, 2009 | 74 | 2009 |
Synthesis and Anticancer and Antiviral Activities of New 2‐Pyrazoline‐Substituted 4‐Thiazolidinones D Havrylyuk, B Zimenkovsky, O Vasylenko, R Lesyka J. Heterocyclic Chem. 50, E55, 2013 | 71 | 2013 |
Toward optimal Ru (II) photocages: balancing photochemistry, stability, and biocompatibility through fine tuning of steric, electronic, and physiochemical features D Havrylyuk, K Stevens, S Parkin, EC Glazer Inorganic chemistry 59 (2), 1006-1013, 2020 | 70 | 2020 |
Strained, photoejecting Ru (II) complexes that are cytotoxic under hypoxic conditions J Roque III, D Havrylyuk, PC Barrett, T Sainuddin, J McCain, K Colón, ... Photochemistry and photobiology 96 (2), 327-339, 2020 | 52 | 2020 |
Structure-activity relationships of anticancer ruthenium (II) complexes with substituted hydroxyquinolines D Havrylyuk, BS Howerton, L Nease, S Parkin, DK Heidary, EC Glazer European Journal of Medicinal Chemistry 156, 790-799, 2018 | 50 | 2018 |
Photochemical Properties and Structure–Activity Relationships of RuII Complexes with Pyridylbenzazole Ligands as Promising Anticancer Agents D Havrylyuk, DK Heidary, L Nease, S Parkin, EC Glazer European journal of inorganic chemistry 2017 (12), 1687-1694, 2017 | 48 | 2017 |
Synthesis and antitumor activity of novel 2-thioxo-4-thiazolidinones with benzothiazole moieties L MOSULA, B ZIMENKOVSKY, AVM HAVRYLYUK, IC CHIRIŢĂ, R LESYK Farmacia 57, 3, 2009 | 46 | 2009 |
Biological activities of polypyridyl-type ligands: implications for bioinorganic chemistry and light-activated metal complexes AC Hachey, D Havrylyuk, EC Glazer Current opinion in chemical biology 61, 191-202, 2021 | 44 | 2021 |
Ru (II) photocages enable precise control over enzyme activity with red light D Havrylyuk, AC Hachey, A Fenton, DK Heidary, EC Glazer Nature Communications 13 (1), 3636, 2022 | 41 | 2022 |
Ru (ii) complexes with diazine ligands: Electronic modulation of the coordinating group is key to the design of “dual action” photoactivated agents D Havrylyuk, M Deshpande, S Parkin, EC Glazer Chemical Communications 54 (88), 12487-12490, 2018 | 41 | 2018 |